Literature DB >> 22361377

Evaluation of neuromuscular junction disorders in the electromyography laboratory.

Vern C Juel1.   

Abstract

Neuromuscular junction (NMJ) disorders may be demonstrated using repetitive nerve stimulation (RNS) testing and single-fiber electromyography (SFEMG). RNS testing with low frequency stimulation reduces the safety factor of neuromuscular transmission (NMT) and may elicit decrementing compound muscle action potential (CMAP) responses. Exercise or tetanic nerve stimulation may potentiate acetylcholine release in presynaptic NMT disorders with CMAP facilitation. SFEMG is a selective recording technique assessing MFAPs within the same motor unit. Jitter is increased in NMJ disorders, and is the temporal variability between these MFAPs. Impulse blocking reflects failure of NMT. RNS and SFEMG findings in NMJ disorders are reviewed. Copyright Â
© 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22361377     DOI: 10.1016/j.ncl.2011.12.012

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  4 in total

1.  Comparison of two electrophysiological methods for the assessment of progress in a rat model of nerve repair.

Authors:  Dong Han; Jiuzhou Lu; Lei Xu; Jianguang Xu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Profiling age-related muscle weakness and wasting: neuromuscular junction transmission as a driver of age-related physical decline.

Authors:  Carlos J Padilla; Markus E Harrigan; Hallie Harris; Jan M Schwab; Seward B Rutkove; Mark M Rich; Brian C Clark; W David Arnold
Journal:  Geroscience       Date:  2021-04-24       Impact factor: 7.713

3.  Persistent neuromuscular junction transmission defects in adults with spinal muscular atrophy treated with nusinersen.

Authors:  W David Arnold; Steven Severyn; Songzhu Zhao; David Kline; Matthew Linsenmayer; Kristina Kelly; Marco Tellez; Amy Bartlett; Sarah Heintzman; Jerry Reynolds; Gary Sterling; Tristan Weaver; Kiran Rajneesh; Arthur H M Burghes; Stephen J Kolb; Bakri Elsheikh
Journal:  BMJ Neurol Open       Date:  2021-08-12

4.  Variants in SLC18A3, vesicular acetylcholine transporter, cause congenital myasthenic syndrome.

Authors:  Gina L O'Grady; Corien Verschuuren; Michaela Yuen; Richard Webster; Manoj Menezes; Johanna M Fock; Natalie Pride; Heather A Best; Tatiana Benavides Damm; Christian Turner; Monkol Lek; Andrew G Engel; Kathryn N North; Nigel F Clarke; Daniel G MacArthur; Erik-Jan Kamsteeg; Sandra T Cooper
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.